View in EDS PDF Full Text

ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept study.

Saved in:
Bibliographic Details
Title: ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept study.
Authors: Stergiopoulou D; Analysis of Circulating Tumor Cells, Laboratory of Analytical Chemistry, Department of Chemistry, University of Athens, Athens, Greece., Markou A; Analysis of Circulating Tumor Cells, Laboratory of Analytical Chemistry, Department of Chemistry, University of Athens, Athens, Greece., Nicolo E; Division of Hematology and Medical Oncology, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY, USA., Serafini MS; Division of Hematology and Medical Oncology, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY, USA., Zhang Q; Robert H. Lurie Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago, IL, USA., Zhang Y; Robert H. Lurie Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago, IL, USA., Gerratana L; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Davis AA; Division of Oncology, Washington University, St. Louis, MO, USA., Liu H; Robert H. Lurie Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago, IL, USA., Gradishar WJ; Robert H. Lurie Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago, IL, USA., Reduzzi C; Division of Hematology and Medical Oncology, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY, USA., Cristofanilli M; Division of Hematology and Medical Oncology, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY, USA., Lianidou E; Analysis of Circulating Tumor Cells, Laboratory of Analytical Chemistry, Department of Chemistry, University of Athens, Athens, Greece.
Source: Molecular oncology [Mol Oncol] 2026 May 27. Date of Electronic Publication: 2026 May 27.
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42201922
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Stergiopoulou+D%22">Stergiopoulou D</searchLink>; Analysis of Circulating Tumor Cells, Laboratory of Analytical Chemistry, Department of Chemistry, University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Markou+A%22">Markou A</searchLink>; Analysis of Circulating Tumor Cells, Laboratory of Analytical Chemistry, Department of Chemistry, University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Nicolo+E%22">Nicolo E</searchLink>; Division of Hematology and Medical Oncology, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Serafini+MS%22">Serafini MS</searchLink>; Division of Hematology and Medical Oncology, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+Q%22">Zhang Q</searchLink>; Robert H. Lurie Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Robert H. Lurie Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Gerratana+L%22">Gerratana L</searchLink>; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.<br /><searchLink fieldCode="AU" term="%22Davis+AA%22">Davis AA</searchLink>; Division of Oncology, Washington University, St. Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Liu+H%22">Liu H</searchLink>; Robert H. Lurie Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Gradishar+WJ%22">Gradishar WJ</searchLink>; Robert H. Lurie Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Reduzzi+C%22">Reduzzi C</searchLink>; Division of Hematology and Medical Oncology, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Cristofanilli+M%22">Cristofanilli M</searchLink>; Division of Hematology and Medical Oncology, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Lianidou+E%22">Lianidou E</searchLink>; Analysis of Circulating Tumor Cells, Laboratory of Analytical Chemistry, Department of Chemistry, University of Athens, Athens, Greece.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101308230%22">Molecular oncology</searchLink> [Mol Oncol] 2026 May 27. <i>Date of Electronic Publication: </i>2026 May 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101308230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-0261 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215747891%22">15747891 </searchLink><i>NLM ISO Abbreviation: </i>Mol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42201922
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/1878-0261.70254
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Stergiopoulou D
      – PersonEntity:
          Name:
            NameFull: Markou A
      – PersonEntity:
          Name:
            NameFull: Nicolo E
      – PersonEntity:
          Name:
            NameFull: Serafini MS
      – PersonEntity:
          Name:
            NameFull: Zhang Q
      – PersonEntity:
          Name:
            NameFull: Zhang Y
      – PersonEntity:
          Name:
            NameFull: Gerratana L
      – PersonEntity:
          Name:
            NameFull: Davis AA
      – PersonEntity:
          Name:
            NameFull: Liu H
      – PersonEntity:
          Name:
            NameFull: Gradishar WJ
      – PersonEntity:
          Name:
            NameFull: Reduzzi C
      – PersonEntity:
          Name:
            NameFull: Cristofanilli M
      – PersonEntity:
          Name:
            NameFull: Lianidou E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 05
              Text: 2026 May 27
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1878-0261
          Titles:
            – TitleFull: Molecular oncology
              Type: main
ResultId 1